Cargando…
Prophylaxis of Ocular Infection in the Setting of Intraocular Surgery: Implications for Clinical Practice and Risk Management
In this review we discuss the role of intraocular surgery preoperative prophylaxis. The correct choice of antimicrobial drug is variable in each surgical setting, according to the available strengths of evidence, the anatomical district involved, and the type of procedure. In the ophthalmic surgical...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011360/ https://www.ncbi.nlm.nih.gov/pubmed/36719608 http://dx.doi.org/10.1007/s40123-023-00661-9 |
_version_ | 1784906374596001792 |
---|---|
author | Borgia, Alfredo Mazzuca, Daniela Della Corte, Marcello Gratteri, Nicola Fossati, Giovanni Raimondi, Raffaele Pagano, Luca Scorcia, Vincenzo Giannaccare, Giuseppe |
author_facet | Borgia, Alfredo Mazzuca, Daniela Della Corte, Marcello Gratteri, Nicola Fossati, Giovanni Raimondi, Raffaele Pagano, Luca Scorcia, Vincenzo Giannaccare, Giuseppe |
author_sort | Borgia, Alfredo |
collection | PubMed |
description | In this review we discuss the role of intraocular surgery preoperative prophylaxis. The correct choice of antimicrobial drug is variable in each surgical setting, according to the available strengths of evidence, the anatomical district involved, and the type of procedure. In the ophthalmic surgical field, there has been a progressive shift from antibiotic formulations, which are known to cause antibiotic resistance, to a new class of antiseptic compounds, which proved to be effective not only against bacteria, but also against fungi, protozoa, and viruses. Among these, povidone–iodine (PVI) is a water-soluble polymer that can form a complex with iodine, and the perioperative application of PVI 5–10% eye drop for 3 min is the gold standard for infection prophylaxis. A new formulation of 0.6% PVI eye drop is a new option for infection prophylaxis in the days before surgery. Chlorhexidine is a biguanide compound, which is a valid alternative with a good safety and efficacy profile and is the antiseptic of choice in patients with iodine allergy. New compounds that are currently being studied include polyhexamethylene biguanide (PHMB), picloxydine, ozone, hypochlorous acid (HOCl), and Biosecur. PHMB is a biguanide polymer that was found to be more effective than PVI in in vitro studies for reducing microorganisms and extending the duration of antisepsis, but to date, there are no formulations available on the market for preoperative ocular surgery in which it is present as main ingredient. Ozone is a molecule with oxidizing effect, which showed interesting preliminary results but is not effective against virus, Staphylococcus aureus and Candida albicans. HOCl has a natural bactericidal propriety but its applicability to prophylaxis of ocular infection in the setting of ocular surgery is not established. Biosecur is a non-toxic organic alcohol-free compound that exhibited bactericidal and fungicidal effect versus all common microorganisms and is currently available as an ocular spray. |
format | Online Article Text |
id | pubmed-10011360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-100113602023-03-15 Prophylaxis of Ocular Infection in the Setting of Intraocular Surgery: Implications for Clinical Practice and Risk Management Borgia, Alfredo Mazzuca, Daniela Della Corte, Marcello Gratteri, Nicola Fossati, Giovanni Raimondi, Raffaele Pagano, Luca Scorcia, Vincenzo Giannaccare, Giuseppe Ophthalmol Ther Review In this review we discuss the role of intraocular surgery preoperative prophylaxis. The correct choice of antimicrobial drug is variable in each surgical setting, according to the available strengths of evidence, the anatomical district involved, and the type of procedure. In the ophthalmic surgical field, there has been a progressive shift from antibiotic formulations, which are known to cause antibiotic resistance, to a new class of antiseptic compounds, which proved to be effective not only against bacteria, but also against fungi, protozoa, and viruses. Among these, povidone–iodine (PVI) is a water-soluble polymer that can form a complex with iodine, and the perioperative application of PVI 5–10% eye drop for 3 min is the gold standard for infection prophylaxis. A new formulation of 0.6% PVI eye drop is a new option for infection prophylaxis in the days before surgery. Chlorhexidine is a biguanide compound, which is a valid alternative with a good safety and efficacy profile and is the antiseptic of choice in patients with iodine allergy. New compounds that are currently being studied include polyhexamethylene biguanide (PHMB), picloxydine, ozone, hypochlorous acid (HOCl), and Biosecur. PHMB is a biguanide polymer that was found to be more effective than PVI in in vitro studies for reducing microorganisms and extending the duration of antisepsis, but to date, there are no formulations available on the market for preoperative ocular surgery in which it is present as main ingredient. Ozone is a molecule with oxidizing effect, which showed interesting preliminary results but is not effective against virus, Staphylococcus aureus and Candida albicans. HOCl has a natural bactericidal propriety but its applicability to prophylaxis of ocular infection in the setting of ocular surgery is not established. Biosecur is a non-toxic organic alcohol-free compound that exhibited bactericidal and fungicidal effect versus all common microorganisms and is currently available as an ocular spray. Springer Healthcare 2023-01-31 2023-04 /pmc/articles/PMC10011360/ /pubmed/36719608 http://dx.doi.org/10.1007/s40123-023-00661-9 Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Review Borgia, Alfredo Mazzuca, Daniela Della Corte, Marcello Gratteri, Nicola Fossati, Giovanni Raimondi, Raffaele Pagano, Luca Scorcia, Vincenzo Giannaccare, Giuseppe Prophylaxis of Ocular Infection in the Setting of Intraocular Surgery: Implications for Clinical Practice and Risk Management |
title | Prophylaxis of Ocular Infection in the Setting of Intraocular Surgery: Implications for Clinical Practice and Risk Management |
title_full | Prophylaxis of Ocular Infection in the Setting of Intraocular Surgery: Implications for Clinical Practice and Risk Management |
title_fullStr | Prophylaxis of Ocular Infection in the Setting of Intraocular Surgery: Implications for Clinical Practice and Risk Management |
title_full_unstemmed | Prophylaxis of Ocular Infection in the Setting of Intraocular Surgery: Implications for Clinical Practice and Risk Management |
title_short | Prophylaxis of Ocular Infection in the Setting of Intraocular Surgery: Implications for Clinical Practice and Risk Management |
title_sort | prophylaxis of ocular infection in the setting of intraocular surgery: implications for clinical practice and risk management |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011360/ https://www.ncbi.nlm.nih.gov/pubmed/36719608 http://dx.doi.org/10.1007/s40123-023-00661-9 |
work_keys_str_mv | AT borgiaalfredo prophylaxisofocularinfectioninthesettingofintraocularsurgeryimplicationsforclinicalpracticeandriskmanagement AT mazzucadaniela prophylaxisofocularinfectioninthesettingofintraocularsurgeryimplicationsforclinicalpracticeandriskmanagement AT dellacortemarcello prophylaxisofocularinfectioninthesettingofintraocularsurgeryimplicationsforclinicalpracticeandriskmanagement AT gratterinicola prophylaxisofocularinfectioninthesettingofintraocularsurgeryimplicationsforclinicalpracticeandriskmanagement AT fossatigiovanni prophylaxisofocularinfectioninthesettingofintraocularsurgeryimplicationsforclinicalpracticeandriskmanagement AT raimondiraffaele prophylaxisofocularinfectioninthesettingofintraocularsurgeryimplicationsforclinicalpracticeandriskmanagement AT paganoluca prophylaxisofocularinfectioninthesettingofintraocularsurgeryimplicationsforclinicalpracticeandriskmanagement AT scorciavincenzo prophylaxisofocularinfectioninthesettingofintraocularsurgeryimplicationsforclinicalpracticeandriskmanagement AT giannaccaregiuseppe prophylaxisofocularinfectioninthesettingofintraocularsurgeryimplicationsforclinicalpracticeandriskmanagement |